{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:58:05Z","timestamp":1790611085161,"version":"4.1.0"},"reference-count":6,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2026.35531","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:30:39Z","timestamp":1790609439000},"page":"e2635531","source":"Crossref","is-referenced-by-count":0,"title":["Why Breast Cancer Chemoprevention Remains Unchosen"],"prefix":"10.1001","volume":"9","author":[{"given":"Maryam B.","family":"Lustberg","sequence":"first","affiliation":[{"name":"Yale School of Medicine and Yale Cancer Center, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"issue":"18","key":"zic260269r1","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","article-title":"Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.","volume":"90","author":"Fisher","year":"1998","journal-title":"J Natl Cancer Inst"},{"issue":"9922","key":"zic260269r2","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/S0140-6736(13)62292-8","article-title":"Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial.","volume":"383","author":"Cuzick","year":"2014","journal-title":"Lancet"},{"issue":"9","key":"zic260269r3","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1001\/jama.2019.11885","article-title":"Medication use to reduce risk of breast cancer: US Preventive Services Task Force recommendation statement.","volume":"322","author":"Owens","year":"2019","journal-title":"JAMA"},{"issue":"4","key":"zic260269r4","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1093\/annonc\/mdv590","article-title":"Factors affecting uptake and adherence to breast cancer chemoprevention: a systematic review and meta-analysis.","volume":"27","author":"Smith","year":"2016","journal-title":"Ann Oncol"},{"issue":"9","key":"zic260269r5","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2026.35555","article-title":"Perceptions of chemoprevention among women at high risk for breast cancer.","volume":"9","author":"Eli","year":"2026","journal-title":"JAMA Netw Open"},{"issue":"27","key":"zic260269r6","doi-asserted-by":"publisher","first-page":"4120","DOI":"10.1200\/JCO.2009.25.9655","article-title":"Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients.","volume":"28","author":"Hershman","year":"2010","journal-title":"J Clin Oncol"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2854512\/lustberg_2026_ic_260269_1789761984.42261.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:30:39Z","timestamp":1790609439000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2854512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":6,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.35531","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,28]]}}}